Table 1.
Clinical features | Training set | Test set | ||||
---|---|---|---|---|---|---|
Effective group | Ineffective group | P-value | Effective group | Ineffective group | P-value | |
Age (mean ± SD) | 18.49 ± 9.871 | 14.73 ± 9.331 | 0.171 | 17.14 ± 8.326 | 13.65 ± 8.141 | 0.243 |
Tumor size (mean ± SD) (cm) | 11.79 ± 4.721 | 9.1550 ± 4.06873 | 0.406 | 12.82 ± 4. 324 | 10.01 ± 3.987 | 0.591 |
Tumor site Thigh bone Tibia Humerus |
36 (35.29%) 16 (15.69%) 7 (6.86%) |
15 (14.71%) 5 (4.90%) 2 (1.96%) |
0.315 | 9 (8.82%) 2 (1.96%) 1 (0.98%) |
6 (5.88%) 2 (1.96%) 1 (0.98%) |
0.478 |
With pathological fracture | 21 (20.59%) | 13 (12.75%) | 0.734 | 6 (5.88%) | 3 (2.94%) | 0.565 |
Surgical stage | 0.013 | 0.025 | ||||
II | 47 (46.08%) | 12 (11.76%) | 9 (8.82%) | 5 (4.90%) | ||
III | 12 (11.76%) | 10 (9.80%) | 3 (2.94%) | 4 (3.92%) |